Showing all 4 results

  • ariply 10

    ARIPLY 10 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 10 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 15

    ARIPLY 15 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 15 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 30

    ARIPLY 30 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 30 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More

  • ariply 5

    ARIPLY 5 – Aripiprazole

    For treatment of schizophrenia.
    For treatment of moderate to severe manic states in bipolar disorder type 1
    and for the prevention of new manic episodes in patients who predominantly
    experienced manic episodes and who had previous manic episodes that responded
    to aripiprazole treatment.
    In addition, Ariply 5, 10, 15 are intended:
    For combined treatment in major depressive disorder (MDD) for patients who
    experienced a partial response to therapy.
    For treatment of restlessness associated with an autistic disorder in children
    (ages 6-17).


    ARIPLY 5 – Aripiprazole

    For treatment of schizophrenia. For treatment of moderate to severe manic states in bipolar disorder type 1 and for the prevention of new manic episodes in patients who predominantly experienced manic episodes and who had previous manic episodes that responded to aripiprazole treatment. In addition, Ariply 5, 10, 15 are intended: For combined treatment in major depressive disorder (MDD) for patients who experienced a partial response to therapy. For treatment of restlessness associated with an autistic disorder in children (ages 6-17).

    Read More